Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Publication year range
1.
Foods ; 11(7)2022 Mar 22.
Article in English | MEDLINE | ID: mdl-35406987

ABSTRACT

Kefir beverage is a probiotic food associated with health benefits, containing probiotic microorganisms and biomolecules produced during fermentation. The microbial composition of these beverages varies among countries, geographical regions, and the substrates, therefore, the characterization of kefir beverages is of great relevance in understanding their potential health-promoting and biotechnological applications. Therefore, this study presents the metagenomic and functional characterization of two Chilean kefir beverages, K02 and K03, through shotgun and amplicon-based metagenomic, microbiological, chemical, and biochemical studies. Results show that both beverages' microbiota were mainly formed by Bacteria (>98%), while Eukarya represented less than 2%. Regarding Bacteria, the most abundant genera were Acetobacter (93.43% in K02 and 80.99% in K03) and Lactobacillus (5.72% in K02 and 16.75% in K03), while Kazachstania was the most abundant genus from Eukarya (42.55% and 36.08% in K02 and K03). Metagenomic analyses revealed metabolic pathways for lactose and casein assimilation, biosynthesis of health-promoting biomolecules, and clusters for antibiotic resistance, quorum sensing communication, and biofilm formation. Enzymatic activities, microbial ß-amyloids, and short-chain fatty acids (acetic acid and propionic acid) were also detected in these beverages. Likewise, both kefir beverages inhibited biofilm formation of the opportunistic pathogen Pseudomonas aeruginosa.

2.
Biochem Biophys Res Commun ; 369(2): 761-6, 2008 May 02.
Article in English | MEDLINE | ID: mdl-18313400

ABSTRACT

Fractionation of a petroleum ether extract of Helianthus annuus L. led to the isolation of three diterpene acids: grandiflorolic, kaurenoic and trachylobanoic acids. These compounds were studied for potential anti-inflammatory activity on the generation of inflammatory mediators in lipopolysaccharide (LPS)-activated RAW 264.7 macrophages. At non-toxic concentrations, these compounds reduced, in a concentration-dependent manner nitric oxide (NO), prostaglandin E(2) (PGE(2)) and tumor necrosis factor (TNF-alpha) production, as well as expression of inducible nitric oxide synthase (NOS-2) and cyclooxygenase-2 (COX-2). All diterpenoids displayed significant in vivo anti-inflammatory activity and suppressed the 12-O-tetradecanoylphorbol-13-acetate (TPA)-mouse ear edema. In addition, inhibition of myeloperoxidase (MPO) activity, an index of cellular infiltration, was observed. In summary, our results suggest that the inhibition of the expression of NOS-2, COX-2 and the release of inflammatory cytokines, is responsible for the anti-inflammatory effects of the diterpenoids isolated from H. annuus L. which likely contributes to the pharmacological action of sunflower.


Subject(s)
Anti-Inflammatory Agents/administration & dosage , Cytokines/immunology , Diterpenes/administration & dosage , Helianthus/metabolism , Immunologic Factors/immunology , Macrophages/immunology , Animals , Cell Line , Dose-Response Relationship, Radiation , Macrophages/drug effects , Mice
3.
An. R. Acad. Farm ; 73(3): 725-746, jul. 2007. ilus
Article in Es | IBECS | ID: ibc-62419

ABSTRACT

Desde los albores de la humanidad, las plantas han sido fuente de interés porsus características nutricionales y medicinales. Por ello, se realizó un estudio farmacológicode terpenoides de Helianthus annuus L., optimizando un método deextracción, aislamiento y purificación de dichos metabolitos, para evaluar unaposible actividad farmacológica sobre modelos de inflamación. También se evaluóuna potencial actividad antiinflamatoria utilizando extractos (metanólico y acuoso)de la planta. Se aislaron tres diterpenos, dos kauranos y un traquilobano, mediantetécnicas cromatográficas, identificándose sus estructuras por RMN (1H, 13C) y evaluando su pureza por HPLC. Paralelamente se evaluó la variación estacional delácido grandiflorólico y de la mezcla de ácido kaurenoico y traquilobánico obtenida,en diferentes sumidades de la planta durante su desarrollo, con el fin de determinardónde y cuándo se produce una máxima acumulación del metabolito estudiado,para así obtener una extracción con un mayor rendimiento. Se encontrarondiferencias significativas útiles para el control de calidad de preparados a base deplantas medicinales que contengan algunos de estos metabolitos secundarios. Parael estudio de la actividad farmacológica de los terpenoides y de los extractos, setrabajó sobre dos modelos de inflamación (in vivo e in vitro). En el modelo in vivose evaluó la acción de los compuestos sobre el edema producido por aplicacióntópica de TPA en oreja de ratón, evaluando en paralelo la infiltración leucocitariaen términos de actividad mieloperoxidasa. En este modelo los ácidos kaurenoicoy traquilobánico demostraron actividad antiinflamatoria. En el modelo in vitro seutilizaron cultivos celulares de una línea de macrófagos, evaluando la actividad delos compuestos sobre la liberación de mediadores inflamatorios (NO, PGE2 y TNFa),y sobre la enzima COX, donde se observó que el ácido grandiflorólico y elextracto metanólico mostraron actividad inhibidora sobre la liberación de estosmediadores, además el ácido grandiflorólico mostró actividad inhibidora de laenzima COX. Sin embargo, no se descarta que en las actividades antiinflamatoriasde dichos compuestos estén implicados otros mediadores


Since the dawn of the humanity plants have been a source of interest becauseof their nutritional and medicinal characteristics. For that reason, a pharmacologicstudy of the terpenoids of Helianthus annuus L. was done, optimizing a method ofextraction, isolation and purification of these metabolites in order to evaluate apossible pharmacologic activity in inflammation models. Also, potentialantiinflammatory activity was evaluated using extracts (methanolic and watery) ofthe plant. Three diterpenes, two kauranes and a trachylobane were isolated, bymeans of chromatographic techniques; their structures were identified by RMN(1H, 13C) and their purity was evaluated by HPLC. Parallelly, the seasonal variationof grandiflorolic acid and kaurenoic and the trachylobanic acid mixture obtainedwas evaluated, in different above-ground parts from the plant during itsdevelopment, with the purpose of determining where and when the highestaccumulation of the studied metabolite occurs thus to obtain an extraction withthe greatest yield. Useful significant differences were found for the quality controlof preparations with medicinal plants that contain some of these secondarymetabolites. For the study of the pharmacologic activity of the terpenoids and theextracts, two models of inflammation (in vivo and in vitro) were worked on. In thein vivo model, the action of compounds was evaluated on edema produced by topical application of TPA in mouse ear, evaluating in parallel the leucocitaryinfiltration in terms of mieloperoxidase activity.In this model the kaurenoic and trachylobanic acids demonstratedantiinflammatory activity. In the in vitro model cellular cultures of a line ofmacrophages were used, the activity of compounds on the liberation ofinflammatory mediators (NO, PGE2 and TNF-a), and the COX enzyme wereevaluated, where it was observed that the grandiflorolic acid and the methanolicextract showed inhibiting activity on the liberation of these mediators. Also, thegrandiflorolic acid showed inhibiting activity on the COX enzyme. However, onedoes not rule out other mediators being implicated in the antiinflammatory activities of these said compounds


Subject(s)
Helianthus/analysis , Helianthus/pharmacology , Helianthus/therapeutic use , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/pharmacokinetics , Helianthus/isolation & purification , Anti-Inflammatory Agents/analysis , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/chemical synthesis , Diterpenes/chemical synthesis , Diterpenes/pharmacology , Diterpenes/pharmacokinetics , Diterpenes, Kaurane/pharmacology , Diterpenes, Kaurane/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL
...